Compensation reforms prohibit price- or rebate-linked PBM revenue in Part D, pushing flat service-fee models and broadly capturing affiliates such as rebate GPOs and aggregators. Reform priorities aim ...

Vertical integration and limited PBM competition can distort formulary placement incentives, enabling rebate-driven list price inflation while obscuring true net costs from employers, pharmacies, and ...

This is the only game in town, this is the only vehicle for PBM reform,” State Rep. Hank Zuber stated while explaining the ...

PBMs help insurers streamline drug management and may help negotiate lower drug costs with manufacturers. However, they may also profit from setting prices and controlling pharmacy networks, making ...

The conclusion of the longest government shutdown in history and rising political acrimony rightly receives a great deal of attention but this focus makes it easy to overlook areas where beneficial ...

Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, drug manufacturers, and pharmacies. This gives them a uniquely powerful ...

Prescription spending has increased substantially in recent years, growing to more than $630 billion in the US in 2022. Of that, approximately 51 percent of total pharmaceutical spending was on ...

PhRMA is again turning up the heat on both big insurance companies and their pharmacy benefit managers (PBMs) in a new ad highlighting middlemen that “own it all.” Healthcare consolidation—where big ...